From the journals: JBC
Life-or-death mitochondrial quality control. A novel pathway for DNA mismatch repair. The role of a key player enzyme in cell survival. Read about papers on these topics recently published in the Journal of Biological Chemistry.
Life-or-death mitochondrial quality control

lung tissue shows a mitochondrion.
Apoptosis, or programmed cell death, is a critical process for the homeostasis of cell populations. Disturbances to this mechanism can lead to cancer and other immune and neurodegenerative diseases.
Mitochondrial outer-membrane permeabilization, or MOMP, is a part of the apoptosis pathway that involves mitochondria and one way apoptosis can be activated. Researchers recently discovered an additional mechanism involving cells that are exposed to weak cell stressors, which can evade MOMP-dependent cell death, and coined the term “minority MOMP.” So far, scientists know little about MOMP uniformity in cells and the frequency of minority MOMP.
In a recent in the Journal of Biological Chemistry, Yulia Kushnareva of the La Jolla Institute for Immunology and collaborators performed an imaging-based phenotypic small interference RNA screen to identify the genes that affect MOMP response in individual cells. They set up this system to quantify three cellular phenotypes based on specific genes fused to fluorescent proteins — apoptotic cells with mitochondria that went through MOMP, nonapoptotic cells with intact mitochondria, and atypical cells with mitochondria.
The authors identified genes that were downregulated, including genes involved in mitochondrial dynamics and mitophagy — mitochondria degradation by autophagy — which increased MOMP diversity within cells. The researchers further determined several genes involved in mitochondrial quality control, or MQC, were essential to post-MOMP survival. The authors conclude that the MQC system is a key player that helps reduce minority MOMP, making this mechanism a potential target to improve the toxic effects of anticancer drugs.
A novel pathway for DNA mismatch repair
One of the major DNA repair mechanisms is the DNA mismatch repair, or MMR, system, which corrects replication errors that make it past the proofreading process during DNA replication. Mutations in several components of the MMR system can lead to cancer initiation and progression in a multistep process involving repression of tumor suppression genes and oncogene activation. In eukaryotes, the MMR system functions both in an exonuclease 1, or EXO1, dependent and independent fashion. While the EXO1-dependent mechanism is well known, researchers do not yet fully understand the EXO1-independent mechanism.
In a recent Journal of Biological Chemistry , Lyudmila Kadyrova of the Southern Illinois University School of Medicine and a team of researchers identified a novel EXO1-independent MMR mechanism in which the enzyme DNA2 plays a key role. DNA2 is both a nuclease and a helicase, which means it can both cut and unwind DNA strands.
The scientists showed that the nuclease activity of DNA2 is able to promote an EXO1-independent MMR reaction via a mismatch excision-independent mechanism involving DNA polymerase delta specifically. They further determined that the helicase activity of DNA2 is not necessary for its ability to enhance the MMR reaction. In addition, the researchers showed that DNA2 acts in the EXO1-independent MMR reaction by increasing the strand displacement activity of DNA polymerase delta. The authors conclude these results provide a novel mechanism for MMR in an EXO1-independent fashion.
The role of a key player enzyme in cell survival
Glutathione peroxidase 4, or GPx4, is an antioxidant enzyme that directly reduces peroxidized phospholipids in the cell membrane. It is also an essential regulator of ferroptosis — nonapoptotic cell death induced by lipid peroxidation. Researchers believe GPx4 cytosolic isoform plays a key part in inhibiting ferroptosis in somatic cells; however, they do not yet understand the role of the mitochondrial isoform, or mGPx4, in cell survival.
In a recent Journal of Biological Chemistry , Kunihiro Azuma of the ophthalmology department at the University of Tokyo and collaborators describe how they studied cell survival using mice with conditional knockouts, or KOs, for all GPx4 isoforms that present a cone–rod dystrophylike phenotype.
The authors showed that mGPx4 KO mice lose their cone photoreceptors during maturation, whereas rod photoreceptors persisted through maturation but then gradually degenerated. They also showed that the retina of mGPx4 KO mice presented increased levels of peroxidized phosphatidylethanolamine esterified with docosahexaenoic acid.
Overall, the researchers write, “mGPx4 is essential for the maturation of cone photoreceptors, but not for the maturation of rod photoreceptors, although it is still critical for the survival of rod photoreceptors after maturation.”
Enjoy reading 91影库Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91影库Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.